Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Profit After Tax (2020 - 2025)

Bioventus (BVS) has disclosed Profit After Tax for 6 consecutive years, with $19.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Profit After Tax rose 646.04% year-over-year to $19.3 million, compared with a TTM value of $27.3 million through Dec 2025, up 262.64%, and an annual FY2025 reading of $27.3 million, up 157.97% over the prior year.
  • Profit After Tax was $19.3 million for Q4 2025 at Bioventus, up from $3.2 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $19.3 million in Q4 2025 and bottomed at -$139.2 million in Q2 2023.
  • Average Profit After Tax over 5 years is -$16.6 million, with a median of -$4.9 million recorded in 2023.
  • The sharpest move saw Profit After Tax tumbled 4670.6% in 2022, then surged 646.04% in 2025.
  • Year by year, Profit After Tax stood at -$34.3 million in 2021, then increased by 6.81% to -$31.9 million in 2022, then skyrocketed by 73.67% to -$8.4 million in 2023, then skyrocketed by 57.96% to -$3.5 million in 2024, then soared by 646.04% to $19.3 million in 2025.
  • Business Quant data shows Profit After Tax for BVS at $19.3 million in Q4 2025, $3.2 million in Q3 2025, and $7.4 million in Q2 2025.